UBS AM’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.7M | Buy |
404,384
+340,816
| +536% | +$10.7M | ﹤0.01% | 1242 |
|
|
2025
Q1 | $2.13M | Sell |
63,568
-128,284
| -67% | -$4.3M | ﹤0.01% | 1965 |
|
|
2024
Q4 | $7.52M | Buy |
191,852
+29,169
| +18% | +$1.14M | ﹤0.01% | 1395 |
|
|
2024
Q3 | $6.4M | Buy |
162,683
+217
| +0.1% | +$8.54K | ﹤0.01% | 1446 |
|
|
2024
Q2 | $6.33M | Buy |
162,466
+84,982
| +110% | +$3.31M | ﹤0.01% | 1364 |
|
|
2024
Q1 | $3.34M | Hold |
77,484
| – | – | ﹤0.01% | 1444 |
|
|
2023
Q4 | $3.57M | Buy |
77,484
+8,683
| +13% | +$400K | ﹤0.01% | 1413 |
|
|
2023
Q3 | $2.35M | Buy |
68,801
+15,749
| +30% | +$538K | ﹤0.01% | 1541 |
|
|
2023
Q2 | $1.9M | Hold |
53,052
| – | – | ﹤0.01% | 1682 |
|
|
2023
Q1 | $1.9M | Buy |
53,052
+14,114
| +36% | +$505K | ﹤0.01% | 1682 |
|
|
2022
Q4 | $1.54M | Buy |
38,938
+534
| +1% | +$21.1K | ﹤0.01% | 1658 |
|
|
2022
Q3 | $1.39M | Buy |
38,404
+11,496
| +43% | +$415K | ﹤0.01% | 1783 |
|
|
2022
Q2 | $819K | Sell |
26,908
-1,928
| -7% | -$58.7K | ﹤0.01% | 2073 |
|
|
2022
Q1 | $882K | Buy |
28,836
+774
| +3% | +$23.7K | ﹤0.01% | 2205 |
|
|
2021
Q4 | $877K | Buy |
+28,062
| New | +$877K | ﹤0.01% | 2278 |
|
|
2021
Q3 | – | Sell |
-319,090
| Closed | -$5.94M | – | 2777 |
|
|
2021
Q2 | $5.94M | Sell |
319,090
-15,651
| -5% | -$291K | ﹤0.01% | 1294 |
|
|
2021
Q1 | $5.99M | Sell |
334,741
-3,090
| -0.9% | -$55.3K | ﹤0.01% | 1268 |
|
|
2020
Q4 | $5.2M | Sell |
337,831
-30,448
| -8% | -$468K | ﹤0.01% | 1279 |
|
|
2020
Q3 | $4.08M | Buy |
368,279
+3,522
| +1% | +$39K | ﹤0.01% | 1237 |
|
|
2020
Q2 | $4.57M | Buy |
+364,757
| New | +$4.57M | ﹤0.01% | 1150 |
|